Knockdown of <i>TRIM47</i> Overcomes Paclitaxel Resistance in Ovarian Cancer by Suppressing the TGF‐β Pathway via <i>PPM1A</i>

TRIM47 promoted paclitaxel resistance in ovarian cancer by inducing PPM1A degradation and activating the TGF-β pathway.

Authors

Institutions

Publication Details

Journal
American Journal of Reproductive Immunology
Published
2025-05-28
DOI
https://doi.org/10.1111/aji.70102
Citations
1
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Knockdown of TRIM47 Overcomes Paclitaxel Resistance in Ovarian Cancer by Suppressing the TGF‐β Pathway via PPM1A

Shengjun Chen, Hezhu Wang, Feifei Xu, Xiaojing Chen
1 citations
American Journal of Reproductive Immunology
RNA modifications and cancer
0.81
article

Knockdown of TRIM47 Overcomes Paclitaxel Resistance in Ovarian Cancer by Suppressing the TGF‐β Pathway via PPM1A

Shengjun Chen, Hezhu Wang, Feifei Xu, Xiaojing Chen
article en
1 citations

Abstract

TRIM47 promoted paclitaxel resistance in ovarian cancer by inducing PPM1A degradation and activating the TGF-β pathway.

American Journal of Reproductive ImmunologyVol. 93(6)
Nantong University (CN), Affiliated Hospital of Nantong University (CN), Nantong Tumor Hospital (CN), The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN), Nanjing Medical University (CN)
Good health and well-being
Openalex Percentile: Top 28%
RNA modifications and cancer
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.